HIV Complications and Co-Morbidities

The IMPAACT HIV Complications & Co-morbidities Scientific Committee (newly named the Brain and Mental Health Scientific Committee) aims to determine optimal and feasible methods for the prevention and management of co-infections and co-morbidities of HIV infection and its treatment. 

Priorities include evaluation of:

• Investigating potential neuroprotective and neurotoxic effects of ART to preserve neurocognitive development and mental health in infants, children, and adolescents
• Refining and optimizing the evaluation and treatment of neurocognitive and mental health disorders, particularly executive dysfunction, depression and PTSD
• Evaluating novel preventive and/or therapeutic approaches to high-priority diseases among pediatric populations with or affected by HIV, including respiratory syncytial virus (RSV), working with NIAID and other partners
• Evaluating other co-morbidities and complications of importance for pediatric, adolescent and pregnant populations with HIV, with other partners and NIH institutes

Committee Contacts

Chair: Jackie Hoare
Vice-Chair: Megan McHenry
Operations Center: Jen Libous, Sarah Buisson, and Haley Brozik

Presentations

• 2022 IMPAACT Annual Meeting Complications & Comorbidities Scientific Committee presentations
• 2019 IMPAACT Annual Meeting Complications & Comorbidities Scientific Committee presentations
• 2018 IMPAACT Annual Meeting Complications & Comorbidities Scientific Committee presentations
• 2017 IMPAACT Annual Meeting Complications & Comorbidities Scientific Committee presentations
• 2016 IMPAACT Annual Meeting Complications & Comorbidities Scientific Committee presentations

Studies Within This Research Area